GAM Holding’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-10,000
| Closed | -$798K | – | 536 |
|
|
2017
Q2 | $798K | Hold |
10,000
| – | – | 0.01% | 691 |
|
|
2017
Q1 | $513K | Hold |
10,000
| – | – | 0.01% | 792 |
|
|
2016
Q4 | $374K | Buy |
10,000
+6,320
| +172% | +$236K | 0.01% | 819 |
|
|
2016
Q3 | $249K | Hold |
3,680
| – | – | ﹤0.01% | 861 |
|
|
2016
Q2 | $204K | Buy |
3,680
+1,391
| +61% | +$77.1K | ﹤0.01% | 901 |
|
|
2016
Q1 | $144K | Hold |
2,289
| – | – | ﹤0.01% | 898 |
|
|
2015
Q4 | $215K | Buy |
2,289
+810
| +55% | +$76.1K | ﹤0.01% | 999 |
|
|
2015
Q3 | $119K | Hold |
1,479
| – | – | ﹤0.01% | 1052 |
|
|
2015
Q2 | $177K | Buy |
+1,479
| New | +$177K | ﹤0.01% | 1019 |
|